University of Kentucky Research

Grants Bulletin

July 27, 2009

Clinician Innovation Day - Aug. 4

Do you have an idea? Make it happen! Come to the 1st Annual Clinician Innovation Day.
August 4, 2009
Wethington Building, Room 014
8:15 a.m. – 1 p.m.

Keynote speaker: Thomas J. Fogarty
Professor of Surgery, Stanford University
Inventor of first balloon embolectomy catheter
70+ patents, 30+ startup companies
National Inventors Hall of Fame
Founder, Fogarty Engineering and Fogarty Winery

UK President Lee T. Todd Jr.
Electrical engineering Ph.D., MIT, 6 patents
Founder, Projectron Inc., sold to Hughes Aircraft Co.
Founder, DataBeam Corp., sold to IBM
Senior Vice President, IBM’s Lotus Development Corp.

For more information see www.econdev.uky.edu/innovationday.
RSVP to innovationday@uky.edu.
Continental breakfast and lunch provided.
Free and open to all UK Healthcare professionals.

Sponsored by the UK Office of Commercialization & Economic Development

Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25)

Only one application per health professional school may be submitted for a given receipt date. Contact your College’s Associate Dean for Research for the specific internal deadline and requirements. Please visit http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-08-016.html to see the full announcement.


July 24, 2009

Obama Administration Announces $85 Million for Early Career Research Program- Aug. 3

U.S. Energy Secretary Steven Chu announced today that up to $85 million in funding under the American Recovery and Reinvestment Act will be awarded in early 2010 to support at least 50 early career researchers for five years at U.S. academic institutions and DOE national laboratories. 

"This funding highlights the administration's continued commitment to building the nation's scientific workforce by attracting top emerging researchers to careers in vital areas of basic research," said Secretary Chu. "By investing in scientific researchers in their formative years, we can provide scientists with the resources to do some of their most exciting and productive work." 

To be eligible for the competition, a researcher must be an untenured, tenure-track assistant professor at a U.S. academic institution or a full-time employee at a DOE national laboratory. The applicant must also have received a Ph.D. within the past 10 years. 

Each university award will be at least $150,000 per year for five years to support summer salary and other research expenses. For DOE national laboratories, awards will be at least $500,000 per year for five years to support year-round salary and expenses.

Early career researchers may apply to one of six Office of Science program offices: Advanced Scientific Computing Research; Biological and Environmental Research; Basic Energy Sciences; Fusion Energy Sciences; High Energy Physics; or Nuclear Physics. Proposed research topics must fall within the programmatic priorities of DOE's Office of Science, which are provided in the program announcements. Funding will be competitively awarded on the basis of peer review. Letters of intent are due August 3, 2009 and full proposals are due September 1, 2009. For more, see http://www.science.doe.gov/SC-2/early_career.htm.

Fiscal Compliance Training Series - Aug. 5 - Sept. 9

The Office of Corporate Compliance is pleased to announce the upcoming Clinical Research Fiscal Compliance training series. Clinical research coordinators, principal investigators, grant management staff, billing/charge staff, and other clinical research study personnel are encouraged to attend sessions applicable to their responsibilities.

The five-course training series is offered every Wednesday for two hours, one course per week, from August 5 through September 9, 2009, in room K116 Kentucky Clinic (CCTS conference room) from 1 p.m. to 3 p.m. The attached training grid (pdf) includes course and instructor names as well as dates and times.

Please email Rebecca Scott, rmwalt00@email.uky.edu, to register for courses. Please include the participant's name, email address, department name, and indicate which course(s) the participant will attend. Space is limited to the first 20 respondents per course.

In the very near future these courses will be required training for clinical research staff. Participation in this series will fulfill future obligation – so attend now!

Limited Submissions

  • NIEHS Hazmat Training at DOE Nuclear Weapons Complex
  • NIEHS Hazardous Materials Worker Health and Safety Training

To view these and other limited submission competitions, visit the Proposal Development Office's site.


July 20, 2009

"We Mean Business" Faculty/Business Start-up Share Session - July 30

July 30, 2009
1:00 p.m. - 2:30 p.m.
CCTS Conf. Rm. K116 (located on the 1st floor of the Kentucky Clinic, across from the Optical Store)
Contact: Teri Timmons, teri.timmons@uky.edu, 859-323-0598, RSVP by Monday, July 27

  • Have you ever thought about making the leap from academics to successful entrepreneurship?
  • Would you like to know what resources are available to help you with a business start-up?
  • Would you like to talk to faculty members about their personal experiences in starting their own companies?

If you answered yes to any of these questions, plan to attend.

Panel Participants:

  • Dr. Len Heller, Vice President, Office for Commercialization and Economic Development; CEO & President, Kentucky Technology Inc. (KTI)
  • Dr. Geanie Umberger, Director, Office for Communication and Public-Industry Relations, Center for Clinical and Translational Science, Associate Professor, Dpt. Of Neurobiology
  • Dr. Edward Hall, Director, Spinal Cord and Brain Injury Research Center (SCoBIRC), Professor, Dpt. of Anatomy and Neurobiology; Founder, Stallion Therapeutics Inc.
  • Dr. Audra Stinchcomb, Associate Professor, College of Pharmacy; Chief Scientific Officer, AllTranz Inc.

Presented by the Office for Commercialization & Economic Development and the Center for Clinical and Translational Science.

"Cell Interrupted: a1-Blockade Exploitation Impairs Cancer Metastasis" - Aug. 6

The Dean’s Distinguished Lecture Series
Noon – 1:00 p.m.
(Please bring your lunch. Only cookies and drinks will be provided.)
Thursday, August 6, 2009
Hospital Auditorium, HG611

Natasha Kyprianou, M.D., Ph.D., James F. Hardymon Chair of Urology Research Professor of Urology, Molecular Biochemistry, and Pathology University of Kentucky

Objectives:

  1. To explain a unique mode of cell death, anoikis and its significance in cancer metastasis.
  2. To provide an insight into the anti-tumor mechanism of novel compounds derived from α1-adrenoceptor antagonists.
  3. To identify the therapeutic value of anoikis induction by the quinazoline drugs for targeting metastatic cancer.

Sponsored by Jay A. Perman, M.D., Dean, College of Medicine

Limited Submissions

  • Dept. of State - Iraq Elections-Related Proposals
  • Dept. of State - Iraq Post-Election Initiative Proposals
  • NEA Statewide Forums on Careers in the Arts for Individuals with Disabilities
  • NEA American Masterpieces

To view these and other limited submission competitions, visit the Proposal Development Office's site.


July 10, 2009

Clarification of the Instructions for Applications to the Initiative for Maximizing Student Development (IMSD) Program (PAR-09-104)

NOT-GM-09-025
June 30, 2009
National Institute of General Medical Sciences (NIGMS)

The purpose of this notice is to clarify: (1) the guidelines for the content and format of the Research Plan of IMSD renewal applications and (2) the required program-supported participant information to be included in the Preliminary Studies/Progress Report sections in the Research Plan of renewal applications.

The 25 page limit for the Research Plan (corresponding to PHS 398 sections on Specific Aims, Background and Significance, Preliminary Studies/Progress Report, and Research Design and Methods) for all applications (new and renewal) includes all summarizing data tables, graphs, figures, diagrams and charts. Applicants may use the appendix to include evaluation instruments as well as detailed information that further clarifies the summarized data tables included in the Research Plan. The summarizing data tables in the body of the Research Plan must include clear and precise statements of the location of the required detailed information in the appendix.

Renewal applications must include in the appendix a list of appointed (program-supported) undergraduate (B.S./B.A.) and graduate (Ph.D.) participants, as applicable, including name, contact information (phone, address, email), underrepresented group, gender, current academic status, degree pursued and institution. The Preliminary Studies/ Progress Report section of the Research Plan in renewal applications can include cumulative tables to summarize the required information on program-supported participants. Each summarizing table must include a clear and precise statement of the location of the required detailed information in the appendix.

All other aspects of this FOA remain unchanged.

Limited Submission - U.S. Dept. of State Central American Free Trade Agreement (CAFTA) Programs

To view this and other limited submission competitions, visit the Proposal Development Office's site.

Research Conflict of Interest and Financial Disclosure Policy and Form Are Revised

The increase in partnerships between universities and industry has led to the expectation at all levels of government that universities function as engines of economic development. These relationships will in some cases have the potential for creating financial conflicts of interest. These financial ties are occurring in the context of increased public sensitivity to and concern about financial conflict of interest in the academic setting.

Both the federal government and the academic community have been active in defining their respective responsibilities to assure the integrity of their research activities. These growing and increasingly complex conflicts of interest in interactions with industry led to the modification of the University of Kentucky’s administrative regulation on Research Conflict of Interest and Financial Disclosure Policy (AR II-4.0-4).   

The following recent reports, notices, and bills in Congress reflect the increased attention to the relationship between industry and academic research:

  • The Association of American Medical Colleges and the Association of American Universities’ report, “Protecting Patients, Preserving Integrity, Advancing Health: Accelerating the Implementation of COI Policies in Human Subjects Research”, Feb 2008
  • The Institute of Medicine’s report, “Conflict of Interest in Medical Research, Education, and Practice”, April 2009
  • Federal Register Proposed Rules: 42 CFR Part 50 and 42 CFR Part 94: Advance notice of proposed rulemaking, Department of Health and Human Services, “Responsibility of Applicants  for Promoting Objectivity in Research for Which Public Health Service Funding is Sought and Responsible Prospective Contractors; Request for Comments”  Vol. 74, No.88 Friday May 8, 2009
  • Physicians Payment Sunshine Act – Introduced in 2009- Bill pending in Congress- Purpose: to provide for transparency in the relationship between physicians and applicable manufacturers with respect to payments and other transfers of value and physician ownership or investment interests in manufacturers. The extensive list of reporting requirement includes grants.

The University of Kentucky has amended the Research Financial Interest Disclosure Statement form to incorporate these increased concerns and public sensitivity to conflict of interest issues, particularly those related to human subjects, and to implement changed included in the revised AR.

The Office of Sponsored Projects Administration (OSPA) is announcing that the revised Disclosure of Financial Interest Form, required for externally funded projects and all projects involving human subjects, is now available on the OSPA web site and the direct link to the PDF is here (http://www.uky.edu/eForms/forms/discfin.pdf). Please start using this new form immediately. The new form’s substantive changes include a second set of questions to be answered for research projects that involve human subjects. 

If you have any questions or would like to schedule an information session for a faculty group, please contact Carole Cole, Conflict of Interest Administrator, at 257-9424.

University of Kentucky | UK Research
Updated 7.27.09 by Alicia Gregory

WARNING: Some Web sites to which these materials provide links for the convenience of users are not managed by the University of Kentucky. The University does not review, control or take responsibility for the contents of those sites.